Home/Filings/4/0001213900-18-008111
4//SEC Filing

Schweibold Andrew 4

Accession 0001213900-18-008111

CIK 0001611277other

Filed

Jun 21, 8:00 PM ET

Accepted

Jun 22, 6:17 PM ET

Size

25.1 KB

Accession

0001213900-18-008111

Insider Transaction Report

Form 4
Period: 2018-06-01
Schweibold Andrew
Director10% OwnerOther
Transactions
  • Award

    Common Stock

    2018-06-01+10,182,64610,182,646 total(indirect: By LLC)
  • Award

    Common Stock

    2018-06-01+1,426,2351,426,235 total(indirect: By LLC)
Holdings
  • Series B Preferred Stock

    (indirect: By LLC)
    Exercise: $0.00Common Stock (13,784,201 underlying)
    13,784,201
  • Common Stock

    (indirect: By LLC)
    1,244,444
Transactions
  • Award

    Common Stock

    2018-06-01+1,426,2351,426,235 total(indirect: By LLC)
  • Award

    Common Stock

    2018-06-01+10,182,64610,182,646 total(indirect: By LLC)
Holdings
  • Common Stock

    (indirect: By LLC)
    1,244,444
  • Series B Preferred Stock

    (indirect: By LLC)
    Exercise: $0.00Common Stock (13,784,201 underlying)
    13,784,201
RSF4, LLC
10% OwnerOther
Transactions
  • Award

    Common Stock

    2018-06-01+1,426,2351,426,235 total(indirect: By LLC)
  • Award

    Common Stock

    2018-06-01+10,182,64610,182,646 total(indirect: By LLC)
Holdings
  • Common Stock

    (indirect: By LLC)
    1,244,444
  • Series B Preferred Stock

    (indirect: By LLC)
    Exercise: $0.00Common Stock (13,784,201 underlying)
    13,784,201
RSG5, LLC
10% OwnerOther
Transactions
  • Award

    Common Stock

    2018-06-01+10,182,64610,182,646 total(indirect: By LLC)
  • Award

    Common Stock

    2018-06-01+1,426,2351,426,235 total(indirect: By LLC)
Holdings
  • Series B Preferred Stock

    (indirect: By LLC)
    Exercise: $0.00Common Stock (13,784,201 underlying)
    13,784,201
  • Common Stock

    (indirect: By LLC)
    1,244,444
RSF5, LLC
10% OwnerOther
Transactions
  • Award

    Common Stock

    2018-06-01+1,426,2351,426,235 total(indirect: By LLC)
  • Award

    Common Stock

    2018-06-01+10,182,64610,182,646 total(indirect: By LLC)
Holdings
  • Common Stock

    (indirect: By LLC)
    1,244,444
  • Series B Preferred Stock

    (indirect: By LLC)
    Exercise: $0.00Common Stock (13,784,201 underlying)
    13,784,201
Rosenthal Jonathan
10% OwnerOther
Transactions
  • Award

    Common Stock

    2018-06-01+10,182,64610,182,646 total(indirect: By LLC)
  • Award

    Common Stock

    2018-06-01+1,426,2351,426,235 total(indirect: By LLC)
Holdings
  • Common Stock

    (indirect: By LLC)
    1,244,444
  • Series B Preferred Stock

    (indirect: By LLC)
    Exercise: $0.00Common Stock (13,784,201 underlying)
    13,784,201
Transactions
  • Award

    Common Stock

    2018-06-01+10,182,64610,182,646 total(indirect: By LLC)
  • Award

    Common Stock

    2018-06-01+1,426,2351,426,235 total(indirect: By LLC)
Holdings
  • Series B Preferred Stock

    (indirect: By LLC)
    Exercise: $0.00Common Stock (13,784,201 underlying)
    13,784,201
  • Common Stock

    (indirect: By LLC)
    1,244,444
Footnotes (6)
  • [F1]Received in exchange for an aggregate of 751,890 shares of Bio-Tech Software, Inc. ("BioTrackTHC") stock in connection with its merger into Helix Acquisition Sub, Inc., a wholly-owned subsidiary of the Issuer (the "Merger"). Of the 10,182,646 shares issued to the Reporting Person in connection with the Merger, 343,094 shares are currently being held in escrow and are subject to forfeiture during the eighteen-month period following the Merger to satisfy indemnification obligations of the Issuer, if any.
  • [F2]The Reporting Person and Jonathan Rosenthal are 50/50 owners of Rose Management Group, LLC which is the manager of RSF5, LLC and RSG5, LLC. The Reporting Person disclaims beneficial ownership of the stock held by RSF5, LLC and RSG5, LLC except to the extent of his pecuniary interest therein.
  • [F3]Received in exchange for 146,090 shares of Bio-Tech Software, Inc. ("BioTrackTHC") stock in connection with its merger into Helix Acquisition Sub, Inc., a wholly-owned subsidiary of the Issuer (the "Merger"). Of the 1,426,235 shares issued to the Reporting Person in connection with the Merger, 76,888 shares are currently being held in escrow and are subject to forfeiture during the eighteen-month period following the Merger to satisfy indemnification obligations of the Issuer, if any.
  • [F4]The Reporting Person and Jonathan Rosenthal are 50/50 owners of Rose Capital Fund I GP, LLC which is the sole manager of RSF4, LLC. The Reporting Person disclaims beneficial ownership of the stock held by RSF4, LLC except to the extent of his pecuniary interest therein.
  • [F5]The Series B Preferred Stock converts to the Issuer's Common Stock on a one-for-one basis.
  • [F6]The Series B Preferred Stock is convertible after May 12, 2018.

Issuer

Helix TCS, Inc.

CIK 0001611277

Entity typeother

Related Parties

1
  • filerCIK 0001742797

Filing Metadata

Form type
4
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 6:17 PM ET
Size
25.1 KB